Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho
General Info
Coverage type
Country
Time period covered
January, 2009 - December, 2011
Data type
Scientific literature
Citation
Journal
J Acquir Immune Defic Syndr
Pages
e68-74
Publication year
2011
Suggested citation
Jouquet G, Bygrave H, Kranzer K, Ford N, Gadot L, Lee J, Hilderbrand K, Goemaere E, Vlahakis N, Trivino L, Makakole L, Cleary S. Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho. J Acquir Immune Defic Syndr. 2011; 58(3): e68-74.